The independent source for health policy research, polling, and news.
281 - 300 of 762 Results
Tuesday night's speakers offered positive views on President Donald Trump's handling of the pandemic. The first lady and Trump, himself, took advantage of the trappings of the White House in setting the scene.
As states and communities ban the sale of flavored tobacco products linked to vaping, anti-smoking activists are piggybacking on the momentum to target menthol cigarettes. But some African Americans say menthol cigarette bans will lead to discrimination.
By 2030, an estimated 1 in 5 Californians will be 65 or older, and the state is creating a “master plan” to address their needs. Lawmakers, advocates, local officials and others gathered in Sacramento on Monday to tackle issues of greatest concern, such as long-term care and housing for low-income seniors.
Teams are starting to test vaccines using messenger RNA or chimpanzee cold viruses to inoculate humans. Will their benefits last?
During his Monday speech at the Republican National Convention, President Donald Trump pointed to his two of his recent executive orders as likely to lead to big reductions in prescription drug costs.
Efforts are underway to bring to market a vaccine for valley fever, a fungal infection with COVID-like symptoms that occurs in the deserts of the Southwest. The illness is getting more attention as cases rise and a warming climate threatens to spread it through the West.
California Gov. Gavin Newsom signed off on an array of health care bills that will significantly affect the lives of Californians, including many college students, pregnant women, schoolchildren and dialysis patients.
With millions out of work because of the coronavirus pandemic, fewer payroll taxes are coming in to help keep Medicare’s trust fund intact.
Several states have adopted bans on vaping products, but California isn’t going that far. Instead, cities and counties in the Golden State are stepping in to prohibit the sale of flavored tobacco products within their jurisdictions — or ban the sale of e-cigarettes altogether.
Under ordinary circumstances, these phases of vaccine development can take years to complete. But now, during the age of coronavirus, the timeline is being shortened. Here's an inventory of where things stand.
Chief Justice John Roberts joined the court’s liberals in the 5-4 decision that strikes down a state law requiring doctors performing abortions to have admitting privileges at nearby hospitals.
Four workers died at a facility with one of the largest U.S. outbreaks, but the Occupational Safety and Health Administration never conducted an inspection. It’s a pattern that’s played out across the nation, a KHN investigation finds.
Anthony Fauci is one of the nation's most trusted voices during public health emergencies. As the head of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases since 1984, Fauci has helped guide the nation through the HIV/AIDS epidemic and more recent outbreaks of Ebola and Zika. In this special episode of KHN’s “What the Health?” podcast, Fauci sits down with KHN Editor-in-Chief Elisabeth Rosenthal to talk about how to navigate the next phase of the coronavirus pandemic and what the incoming Biden administration should do first.
The state Senate on Wednesday sent a measure to Democratic Gov. Gavin Newsom that would tighten the rules for children’s medical exemptions from vaccines. Newsom, who said in June that he would sign the measure after amendments had been made at his request, now wants more changes.
Confusion about a new federal rule to restrict legal immigration based on the use of public benefits may dampen sign-ups for health care, housing and food aid even among immigrants not directly targeted by the rule. Here are some answers to frequently asked questions that will help clear up some of the misunderstanding.
California’s stem cell agency, created by a $3 billion bond measure 15 years ago, is almost out of money. Its supporters plan to ask voters for even more funding next year, even though no agency-funded treatments have been approved for widespread use.
The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices.
Trials are an immense undertaking involving tens of thousands of participants. They’re likely to start this summer — but don’t expect quick results. And what’s a successful result, anyway?
Congress authorized $100 billion for health care providers to help reimburse them for losses linked to the coronavirus pandemic. But the majority of that funding so far has gone to hospitals, doctors and other facilities that serve Medicare patients. Providers primarily serving low-income Medicaid populations and children have been largely left out.
As California Attorney General Xavier Becerra cracks down on pharmaceutical companies he said paid competitors to delay generic versions of their drugs, he’s also pushing for legislation that would give his department tools to catch more of them. It’s the first of its kind in the nation.
© 2026 KFF